Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis

Clinical trial NCT04878003 · UNKNOWN

Trial details

NCT number: NCT04878003
Sponsor: Kartos Therapeutics, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis (PMF)Post-Polycythemia Vera Myelofibrosis (Post-PV-MF)Post-Essential Thrombocythemia Myelofibrosis (Post-ET-MF)

Start date: 2021-04-13
Primary completion: 2024-05-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.